Analysis of GFAP Variants in UK Biobank Suggests Underdiagnosis or Incomplete Penetrance of Adult-Onset Alexander Disease

The article “Analysis of GFAP Variants in UK Biobank Suggests Underdiagnosis or Incomplete Penetrance of Adult-Onset Alexander Disease” investigates the prevalence and clinical significance of mutations in the GFAP gene, which are linked to Alexander disease. This rare neurodegenerative disorder affects the white matter of the central nervous system, leading to a progressive decline in motor and cognitive functions.

By analyzing genetic and clinical data from the UK Biobank, the study identifies individuals carrying pathogenic or likely pathogenic GFAP variants. The findings reveal that these mutations are more common in the population than previously understood, suggesting that Alexander disease is potentially underdiagnosed or misdiagnosed, particularly in adult-onset cases. The data also highlight that some individuals with these variants may not develop the disease, pointing to incomplete penetrance of the condition.

The study underscores the importance of recognizing Alexander disease as a possible diagnosis in patients presenting with unexplained neurological symptoms, even in adulthood. By improving awareness and diagnostic criteria, clinicians may better identify and manage cases of this rare disorder. This research contributes to a growing understanding of Alexander disease and suggests a need for further studies on the genetic and clinical variability of the condition.

For more details, the full article can be accessed here.

*The United Leukodystrophy Foundation is not liable for any inaccuracies or gaps in these overviews , which are offered “as is” without assurances on completeness, accuracy, or timeliness. For verification or detailed information, please consult the original articles directly.
As a leukodystrophy related nonprofit, the ULF provides awareness to scientific literature. Inclusion on our website does not imply endorsement of, or agreement with, the contents by the ULF.